| Literature DB >> 31577934 |
Samir Softic1, Jesse G Meyer2, Guo-Xiao Wang3, Manoj K Gupta4, Thiago M Batista3, Hans P M M Lauritzen3, Shiho Fujisaka5, Dolors Serra6, Laura Herrero6, Jennifer Willoughby7, Kevin Fitzgerald7, Olga Ilkayeva8, Christopher B Newgard8, Bradford W Gibson2, Birgit Schilling2, David E Cohen9, C Ronald Kahn10.
Abstract
Dietary sugars, fructose and glucose, promote hepatic de novo lipogenesis and modify the effects of a high-fat diet (HFD) on the development of insulin resistance. Here, we show that fructose and glucose supplementation of an HFD exert divergent effects on hepatic mitochondrial function and fatty acid oxidation. This is mediated via three different nodes of regulation, including differential effects on malonyl-CoA levels, effects on mitochondrial size/protein abundance, and acetylation of mitochondrial proteins. HFD- and HFD plus fructose-fed mice have decreased CTP1a activity, the rate-limiting enzyme of fatty acid oxidation, whereas knockdown of fructose metabolism increases CPT1a and its acylcarnitine products. Furthermore, fructose-supplemented HFD leads to increased acetylation of ACADL and CPT1a, which is associated with decreased fat metabolism. In summary, dietary fructose, but not glucose, supplementation of HFD impairs mitochondrial size, function, and protein acetylation, resulting in decreased fatty acid oxidation and development of metabolic dysregulation.Entities:
Keywords: acetylation; fatty acid oxidation; fatty liver disease; fructose; glucose; ketohexokinase; mass spectrometry; mitochondria; obesity; sugar
Mesh:
Substances:
Year: 2019 PMID: 31577934 PMCID: PMC7816129 DOI: 10.1016/j.cmet.2019.09.003
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287